Delivery Order SPE2DR25D1104-SPE2DR26FK100
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,331.98 to AmerisourceBergen Drug Corp for Lupron Depot 45 mg 6-month kits under a firm fixed price contract. The award was issued on July 24, 2025, with an ultimate completion date of July 25, 2025. This delivery order represents a non-set-aside award issued competitively to AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania, where the company is headquartered. Lupron Depot is a hormone therapy...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,201.87 for Lupron Depot 11.25 mg 3-month kits, with an ultimate completion date of September 4, 2025. This is a firm fixed price delivery order under a non-set-aside competitive procurement. The contractor, headquartered in Conshohocken, Pennsylvania, will perform work at its corporate office location. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on April 30, 2025, for the supply of Lupron Depot 11.25 mg three-month kits, valued at $34,676.08. This non-set-aside, competitively awarded contract employs firm fixed pricing and is scheduled for completion by May 1, 2025. AmerisourceBergen will perform this work from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a leading pharmaceutical...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $6,712.23 to AmerisourceBergen Drug Corp on September 19, 2025, for Lupron Depot 11.25 mg 3-month kits, with an ultimate completion date of September 22, 2025. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award to the vendor. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,566.68 to AmerisourceBergen Drug Corp for Lupron Depot 45 mg 6-month kits, a specialty pharmaceutical product used in hormone therapy and cancer treatment. The contract was awarded on July 16, 2025, with an ultimate completion date of July 17, 2025, under firm fixed-price terms with no set-aside designation. Performance will be conducted at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for Lupron Depot 45 mg 6-month kits, with a ceiling value of $1,371.86. This is a firm fixed-price delivery order with an ultimate completion date of August 21, 2025. The contract is not set-aside and was awarded competitively to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania. The place of performance is the...
- The Defense Logistics Agency awarded a delivery order valued at $17,759.51 to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded with a completion date of September 9, 2025. The award was made to AmerisourceBergen's corporate office, with performance to be executed at the company's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency's Medical Supply Chain has awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month treatment kits under a firm fixed-price contract. The award, valued at $47,687.90 and dated April 23, 2025, represents a single delivery order with an ultimate completion date of April 24, 2025. This contract was competitively awarded with no set-aside designation, and performance will be executed from the contractor's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Lupron Depot 11.25 mg 3-month kits valued at $46,242.51 under a firm fixed-price contract type. The order was competitively awarded with no set-aside designation and is scheduled for completion by September 22, 2025. AmerisourceBergen will perform the delivery from its corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 20, 2025, for the supply of Lupron Depot 11.25 mg 3-month kits valued at $10,499.78. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded under open competition. The order is scheduled for ultimate completion by June 23, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a major pharmaceutical...
- SPE2DR25D1104Indefinite Delivery Contract
- SPE2DR25D1104-SPE2DR26FK100Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Lupron Depot 45 mg 6-month kits valued at $3,086.97 under a firm fixed price contract. The award was issued on October 21, 2025, with an ultimate completion date of October 22, 2025, and represents a non-set-aside competitive procurement. The product will be performed from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its headquarters as a major pharmaceutical distributor serving federal medical procurement needs. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling AmerisourceBergen to supply a broad range of pharmaceutical products and medical commodities to support military healthcare programs worldwide. The underlying IDC encompasses specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains, supporting customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.1k | 10/21/25 |